Disparities in access to novel infusion treatment for Alzheimer’s disease revealed The adoption of Lecanemab, a new infusion treatment for Alzheimer’s disease (AD), has been disproportionately higher in patients who are…
Social and health disparities drive brain aging in Latin America Research reveals the unique risk factors of Brazil, with education as the best predictor of cognitive decline, in contrast to…
AI model predicts Alzheimer’s progression with new insights into racial and sex-based disparities A groundbreaking AI model analyzes diverse data to reveal faster progression of Alzheimer’s disease in Black women, providing a powerful…
